Michael Palfreyman
Chief Tech/Sci/R&D Officer presso Amorsa Therapeutics, Inc.
Patrimonio netto: 399 712 $ in data 31/03/2024
Profilo
Michael Gavin Palfreyman is currently a Director at Amakem NV, Chief Operating Officer & Director at Adelia Therapeutics, Inc., and Chief Scientific Officer at Amorsa Therapeutics, Inc. He previously held positions as Chief Scientific Officer at Marc Pharmaceuticals, Inc., VP-Program Management & Product Development at FORUM Pharmaceuticals, Inc., Principal at Psychiatric Genomics, Inc. and Torrey Pines Investment, Inc., and Chief Research & Development Officer at Cybin, Inc. Palfreyman received his doctorate degree from The University of Nottingham in 1970, his undergraduate degree in 1967, and his graduate degree in 1971.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CYBIN, INC.
0.23% | 12/01/2023 | 965 488 ( 0.23% ) | 399 712 $ | 31/03/2024 |
Posizioni attive di Michael Palfreyman
| Società | Posizione | Inizio |
|---|---|---|
Amakem NV
 Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Director/Board Member | 25/08/2011 |
Adelia Therapeutics, Inc.
 Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | Chief Operating Officer | - |
Amorsa Therapeutics, Inc.
 Amorsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amorsa Therapeutics, Inc. is an American neuron pharmaceutical company. The private company is based in Southborough. | Chief Tech/Sci/R&D Officer | 01/04/2013 |
Precedenti posizioni note di Michael Palfreyman
| Società | Posizione | Fine |
|---|---|---|
| CYBIN INC. | Chief Tech/Sci/R&D Officer | 05/06/2023 |
Torrey Pines Investment, Inc.
 Torrey Pines Investment, Inc. Investment ManagersFinance Torrey Pines Investment, Inc (Torrey Pines Investment) is a venture capital firm is founded in 2002 by Nikolay Savchuk.The firm is headquartered San Diego, California. | Private Equity Investor | - |
Psychiatric Genomics, Inc.
 Psychiatric Genomics, Inc. Pharmaceuticals: MajorHealth Technology Psychiatric Genomics, Inc. developed innovative small molecule drugs. It identified gene expression patterns associated with psychiatric diseases. The company was incorporated on June 21, 2000 and was headquartered in Rockville, MD. | Corporate Officer/Principal | - |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Marc Pharmaceuticals, Inc.
 Marc Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Marc Pharmaceuticals, Inc. operates as a development stage pharmaceutical company. The company is headquartered in Stamford, CT. | Chief Tech/Sci/R&D Officer | - |
Formazione di Michael Palfreyman
| The University of Nottingham | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CYBIN INC. | Health Technology |
| Aziende private | 7 |
|---|---|
Marc Pharmaceuticals, Inc.
Marc Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Marc Pharmaceuticals, Inc. operates as a development stage pharmaceutical company. The company is headquartered in Stamford, CT. | Health Technology |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Health Technology |
Psychiatric Genomics, Inc.
Psychiatric Genomics, Inc. Pharmaceuticals: MajorHealth Technology Psychiatric Genomics, Inc. developed innovative small molecule drugs. It identified gene expression patterns associated with psychiatric diseases. The company was incorporated on June 21, 2000 and was headquartered in Rockville, MD. | Health Technology |
Torrey Pines Investment, Inc.
Torrey Pines Investment, Inc. Investment ManagersFinance Torrey Pines Investment, Inc (Torrey Pines Investment) is a venture capital firm is founded in 2002 by Nikolay Savchuk.The firm is headquartered San Diego, California. | Finance |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Health Services |
Amorsa Therapeutics, Inc.
Amorsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amorsa Therapeutics, Inc. is an American neuron pharmaceutical company. The private company is based in Southborough. | Health Technology |
Adelia Therapeutics, Inc.
Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | Health Technology |
- Borsa valori
- Insiders
- Michael Palfreyman
